Arkolith/Insider Trading/VRDN/Form 4

Fairmount Healthcare Fund II L.P.

Director, 10% OwnerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Apr 1, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2024Other(J)6K——0
Mar 28, 2024Other(J)6K——1.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 28, 2024Other(J)22K—$0133K
Mar 28, 2024Other(J)22K—$00

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-039599) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML